Literature DB >> 67389

Does Gilbert's disease exist?

A Bailey, D Robinson, A M Dawson.   

Abstract

18 454 men and 5471 women attending a screening centre had serum-bilirubin concentrations measured. 2.0% of men and 0.6% of women had concentrations of 25 micronmol/1 (1-5 MG/DL) or above. Both sexes showed skewed distributions for bilirubin concentration, but analysis of the data showed no evidence of bimodality for either sex. This suggests that people who are now diagnosed as having Gilbert's disease may constitute upper end of the normal range rather than a disease state. The term "constitutional hyperbilirubinaemia" is preferable, and its use can be coupled with reassurance to the patient that the condition causes no symptoms.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 67389     DOI: 10.1016/s0140-6736(77)92226-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  8 in total

Review 1.  Twenty-five years of progress in bilirubin metabolism (1952-77).

Authors:  B H Billing
Journal:  Gut       Date:  1978-06       Impact factor: 23.059

2.  A study of hyperbilirubinaemia in clinical practice.

Authors:  R J Abbott; M D Clee; N W Carter; I A Bouchier
Journal:  Postgrad Med J       Date:  1979-11       Impact factor: 2.401

Review 3.  Hepatic transport and metabolism of various organic anions in patients with congenital non-hemolytic hyperbilirubinemia, including constitutional indocyanine green excretory defect.

Authors:  M Nambu; T Namihisa
Journal:  J Gastroenterol       Date:  1994-04       Impact factor: 7.527

4.  Clinical value of bile salt tests in anicteric liver disease.

Authors:  J G Douglas; G J Beckett; I A Nimmo; N D Finlayson; I W Percy-Robb
Journal:  Gut       Date:  1981-02       Impact factor: 23.059

5.  Lipids and lipoproteins in Friedreich's ataxia.

Authors:  J L Walker; S Chamberlain; N Robinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-02       Impact factor: 10.154

Review 6.  Gilbert's syndrome and drug metabolism.

Authors:  A F Macklon; R L Savage; M D Rawlins
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

7.  Hepatic transport of serum bilirubin, bromsulfophthalein, and indocyanine green in patients with congenital non-hemolytic hyperbilirubinemia and patients with constitutional indocyanine green excretory defect.

Authors:  M Nambu; T Namihisa
Journal:  J Gastroenterol       Date:  1996-04       Impact factor: 7.527

8.  Hepatic bilirubin-conjugating enzymes of man in the normal state and in liver disease.

Authors:  Y Adachi; T Yamamoto
Journal:  Gastroenterol Jpn       Date:  1982
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.